Clinical Trials Directory

Trials / Completed

CompletedNCT00296478

Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
1,211 (actual)
Sponsor
Ferring Pharmaceuticals · Industry
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Accepted

Summary

This multicenter, randomized, open-label study will be performed in approximately 990 healthy females undergoing IVF. Each study center will follow their study center standard practice for IVF unless otherwise noted in this protocol. The study centers will be provided with the medications for down regulation, stimulation and ovulation induction. The subjects will be randomized to study medication on the day of oocyte retrieval or the day following and will continue treatment for up to 10 weeks. The subjects with a confirmed pregnancy will be required to return to the clinic several times during the course of the 10 week treatment period for serum pregnancy tests and transvaginal ultrasounds to monitor the pregnancy.

Detailed description

This multicenter, randomized, open-label study will be performed in approximately 990 healthy females undergoing IVF. Each study center will follow their study center standard practice for IVF unless otherwise noted in this protocol. The study centers will be provided with the medications for down regulation, stimulation and ovulation induction. The subjects will be randomized to study medication on the day of oocyte retrieval or the day following and will continue treatment for up to 10 weeks. The subjects with a confirmed pregnancy will be required to return to the clinic several times during the course of the 10 week treatment period for serum pregnancy tests and transvaginal ultrasounds to monitor the pregnancy.

Conditions

Interventions

TypeNameDescription
DRUGEndometrinEndometrin 100mg BID x 10weeks
DRUGEndometrinEndometrin 100mg TID x 10weeks
DRUGCrinoneCrinone QD x 10weeks

Timeline

Start date
2005-07-01
Primary completion
2006-04-01
Completion
2006-07-01
First posted
2006-02-27
Last updated
2011-05-19

Source: ClinicalTrials.gov record NCT00296478. Inclusion in this directory is not an endorsement.